TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

TransMedics Group, Inc. Common Stock

Transmedics develops and offers medical technology products that focus on organ transplantation, specifically through the Organ Care System.

COM:TRANSMEDICS

Transmedics

Last Close

79.34

22/11 21:00

Market Cap

2.55B

Beta: -

Volume Today

2.60M

Avg: -

Financials Not Available